EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Two-year clinical outcomes of standalone gonioscopy-assisted transluminal trabeculotomy in normal-tension glaucoma

Zhengfang Wu, Suju Liu, Ping Yu, Xiao Tang, Liuzhi Zeng

Frontiers in Medicine · 17.04.2026 · 13

DOI: 10.3389/fmed.2026.1828249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 17.04.2026. Verfasst von Zhengfang Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the 2-year efficacy and safety of gonioscopy-assisted transluminal trabeculotomy (GATT) for normal-tension glaucoma (NTG).

Methods

This single-center retrospective case series included 9 NTG patients (12 eyes) undergoing GATT, with follow-up at postoperative day 1, week 1, and months 1, 3, 6, 12, 18, and 24. Primary outcomes were changes in intraocular pressure (IOP) and IOP-lowering medication burden at 24 months (counted by active ingredients). Complete and qualified success were assessed using strict criteria (from postoperative month 1 onward: IOP 6–15 mmHg and ≥20% reduction from baseline). Postoperative events and additional interventions/reoperations were recorded. Paired t tests or Wilcoxon signed-rank tests were used as appropriate; a one-eye-per-patient sensitivity analysis was performed.

Results

The median age at surgery was 65 (53–70) years, and most eyes had moderate-to-advanced glaucoma. Mean IOP decreased from 17.33 ± 3.53 mmHg to 13.33 ± 2.35 mmHg at 24 months (mean reduction 4.00 ± 2.86 mmHg; 95% CI 2.18–5.82; t = 4.844; p < 0.001), corresponding to a 23.1% reduction. Medication burden decreased from 1 (0, 2) to 0 (0, 0) ( Z = −2.251; p = 0.024). At 24 months, qualified and complete success rates were both 50.0% (6/12); sensitivity analysis ( n = 9) was consistent. No hypotony, IOP spikes, or serious complications occurred. Events were mild and self-limited (mainly hyphema and aqueous flare). No SLT, needling, or additional glaucoma surgery was required.

Conclusion

GATT significantly reduced IOP and medication burden in NTG with a safety profile through 24 months. Larger prospective studies are warranted.

Schlagwörter

Stichwörter der Autor:innen

IOP-lowering medicationsgonioscopy-assisted transluminal trabeculotomyintraocular pressureminimally invasive glaucoma surgerynormal-tension glaucomasafety

Autor:innen und Institutionen

  • Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Chengdu University of Traditional Chinese Medicine (Chengdu First People's Hospital), High-Tech Zone, Chengdu, Sichuan, China.

Zitieren

APA

Wu, Z., Liu, S., Yu, P., Tang, X., & Zeng, L. (2026). Two-year clinical outcomes of standalone gonioscopy-assisted transluminal trabeculotomy in normal-tension glaucoma. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1828249

Vancouver

Wu Z, Liu S, Yu P, Tang X, Zeng L. Two-year clinical outcomes of standalone gonioscopy-assisted transluminal trabeculotomy in normal-tension glaucoma. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1828249

BibTeX
@article{Wu2026,
  author = {Wu, Zhengfang and Liu, Suju and Yu, Ping and Tang, Xiao and Zeng, Liuzhi},
  title = {Two-year clinical outcomes of standalone gonioscopy-assisted transluminal trabeculotomy in normal-tension glaucoma},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1828249}
}
Kostenlos starten →